nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.35	1	CbGbCtD
Maprotiline—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.024	0.115	CbGeAlD
Maprotiline—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0233	0.0569	CcSEcCtD
Maprotiline—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0398	CcSEcCtD
Maprotiline—Sertraline—SIGMAR1—amyotrophic lateral sclerosis	0.0138	1	CrCbGaD
Maprotiline—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0307	CcSEcCtD
Maprotiline—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.012	0.0294	CcSEcCtD
Maprotiline—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0247	CcSEcCtD
Maprotiline—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.01	0.048	CbGeAlD
Maprotiline—HTR7—pons—amyotrophic lateral sclerosis	0.0099	0.0474	CbGeAlD
Maprotiline—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00867	0.0212	CcSEcCtD
Maprotiline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00859	0.021	CcSEcCtD
Maprotiline—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00859	0.021	CcSEcCtD
Maprotiline—Mania—Riluzole—amyotrophic lateral sclerosis	0.00836	0.0204	CcSEcCtD
Maprotiline—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00807	0.0197	CcSEcCtD
Maprotiline—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00794	0.0194	CcSEcCtD
Maprotiline—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00739	0.018	CcSEcCtD
Maprotiline—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00733	0.0179	CcSEcCtD
Maprotiline—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00707	0.0173	CcSEcCtD
Maprotiline—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00673	0.0164	CcSEcCtD
Maprotiline—SLC6A3—nerve—amyotrophic lateral sclerosis	0.0066	0.0316	CbGeAlD
Maprotiline—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00659	0.0316	CbGeAlD
Maprotiline—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0157	CcSEcCtD
Maprotiline—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00625	0.0299	CbGeAlD
Maprotiline—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00619	0.0151	CcSEcCtD
Maprotiline—HTR2A—pons—amyotrophic lateral sclerosis	0.00617	0.0296	CbGeAlD
Maprotiline—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00608	0.0148	CcSEcCtD
Maprotiline—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00533	0.0255	CbGeAlD
Maprotiline—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00527	0.0252	CbGeAlD
Maprotiline—HTR7—nerve—amyotrophic lateral sclerosis	0.00514	0.0246	CbGeAlD
Maprotiline—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00495	0.0237	CbGeAlD
Maprotiline—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00493	0.012	CcSEcCtD
Maprotiline—DRD2—nerve—amyotrophic lateral sclerosis	0.00486	0.0233	CbGeAlD
Maprotiline—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0116	CcSEcCtD
Maprotiline—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0047	0.0115	CcSEcCtD
Maprotiline—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0112	CcSEcCtD
Maprotiline—HTR2A—appendage—amyotrophic lateral sclerosis	0.00452	0.0216	CbGeAlD
Maprotiline—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0108	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0107	CcSEcCtD
Maprotiline—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0105	CcSEcCtD
Maprotiline—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0042	0.0102	CcSEcCtD
Maprotiline—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00415	0.0101	CcSEcCtD
Maprotiline—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00411	0.0197	CbGeAlD
Maprotiline—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00995	CcSEcCtD
Maprotiline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00984	CcSEcCtD
Maprotiline—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00399	0.00973	CcSEcCtD
Maprotiline—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0095	CcSEcCtD
Maprotiline—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00385	0.0184	CbGeAlD
Maprotiline—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00931	CcSEcCtD
Maprotiline—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00364	0.0174	CbGeAlD
Maprotiline—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00884	CcSEcCtD
Maprotiline—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00352	0.0086	CcSEcCtD
Maprotiline—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00857	CcSEcCtD
Maprotiline—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0085	CcSEcCtD
Maprotiline—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00847	CcSEcCtD
Maprotiline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00842	CcSEcCtD
Maprotiline—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0083	CcSEcCtD
Maprotiline—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0083	CcSEcCtD
Maprotiline—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00818	CcSEcCtD
Maprotiline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00814	CcSEcCtD
Maprotiline—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00814	CcSEcCtD
Maprotiline—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00809	CcSEcCtD
Maprotiline—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00809	CcSEcCtD
Maprotiline—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00785	CcSEcCtD
Maprotiline—HTR2A—nerve—amyotrophic lateral sclerosis	0.0032	0.0153	CbGeAlD
Maprotiline—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00775	CcSEcCtD
Maprotiline—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00745	CcSEcCtD
Maprotiline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00741	CcSEcCtD
Maprotiline—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00741	CcSEcCtD
Maprotiline—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00736	CcSEcCtD
Maprotiline—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00731	CcSEcCtD
Maprotiline—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00705	CcSEcCtD
Maprotiline—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00696	CcSEcCtD
Maprotiline—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00284	0.0136	CbGeAlD
Maprotiline—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00692	CcSEcCtD
Maprotiline—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00278	0.0133	CbGeAlD
Maprotiline—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00676	CcSEcCtD
Maprotiline—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00672	CcSEcCtD
Maprotiline—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00274	0.0131	CbGeAlD
Maprotiline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00666	CcSEcCtD
Maprotiline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00659	CcSEcCtD
Maprotiline—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00267	0.0128	CbGeAlD
Maprotiline—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00649	CcSEcCtD
Maprotiline—Tension—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00637	CcSEcCtD
Maprotiline—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00635	CcSEcCtD
Maprotiline—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00258	0.0063	CcSEcCtD
Maprotiline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00608	CcSEcCtD
Maprotiline—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00596	CcSEcCtD
Maprotiline—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.0024	0.0115	CbGeAlD
Maprotiline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00582	CcSEcCtD
Maprotiline—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00581	CcSEcCtD
Maprotiline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00573	CcSEcCtD
Maprotiline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0057	CcSEcCtD
Maprotiline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00562	CcSEcCtD
Maprotiline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0056	CcSEcCtD
Maprotiline—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00229	0.011	CbGeAlD
Maprotiline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00225	0.0055	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00548	CcSEcCtD
Maprotiline—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0054	CcSEcCtD
Maprotiline—HTR7—brainstem—amyotrophic lateral sclerosis	0.0022	0.0106	CbGeAlD
Maprotiline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00534	CcSEcCtD
Maprotiline—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00219	0.0105	CbGeAlD
Maprotiline—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00217	0.0104	CbGeAlD
Maprotiline—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00529	CcSEcCtD
Maprotiline—Infection—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00526	CcSEcCtD
Maprotiline—Shock—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00521	CcSEcCtD
Maprotiline—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00519	CcSEcCtD
Maprotiline—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00518	CcSEcCtD
Maprotiline—CHRM4—brain—amyotrophic lateral sclerosis	0.00212	0.0102	CbGeAlD
Maprotiline—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00517	CcSEcCtD
Maprotiline—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00514	CcSEcCtD
Maprotiline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00512	CcSEcCtD
Maprotiline—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00209	0.01	CbGeAlD
Maprotiline—DRD2—brainstem—amyotrophic lateral sclerosis	0.00208	0.00999	CbGeAlD
Maprotiline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00495	CcSEcCtD
Maprotiline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00479	CcSEcCtD
Maprotiline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00475	CcSEcCtD
Maprotiline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00471	CcSEcCtD
Maprotiline—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00191	0.00916	CbGeAlD
Maprotiline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00466	CcSEcCtD
Maprotiline—ORM1—spinal cord—amyotrophic lateral sclerosis	0.0019	0.00908	CbGeAlD
Maprotiline—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00457	CcSEcCtD
Maprotiline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00456	CcSEcCtD
Maprotiline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00453	CcSEcCtD
Maprotiline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00436	CcSEcCtD
Maprotiline—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00433	CcSEcCtD
Maprotiline—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00176	0.00845	CbGeAlD
Maprotiline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00421	CcSEcCtD
Maprotiline—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00419	CcSEcCtD
Maprotiline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00419	CcSEcCtD
Maprotiline—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.0017	0.00817	CbGeAlD
Maprotiline—CHRM5—brain—amyotrophic lateral sclerosis	0.00166	0.00795	CbGeAlD
Maprotiline—ORM1—nervous system—amyotrophic lateral sclerosis	0.0016	0.00765	CbGeAlD
Maprotiline—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00159	0.00764	CbGeAlD
Maprotiline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0038	CcSEcCtD
Maprotiline—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00154	0.00737	CbGeAlD
Maprotiline—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00154	0.00737	CbGeAlD
Maprotiline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00375	CcSEcCtD
Maprotiline—HTR2A—embryo—amyotrophic lateral sclerosis	0.0015	0.00719	CbGeAlD
Maprotiline—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00149	0.00714	CbGeAlD
Maprotiline—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00149	0.00712	CbGeAlD
Maprotiline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00362	CcSEcCtD
Maprotiline—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00144	0.00688	CbGeAlD
Maprotiline—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00143	0.00687	CbGeAlD
Maprotiline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0035	CcSEcCtD
Maprotiline—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00143	0.00685	CbGeAlD
Maprotiline—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.0014	0.0067	CbGeAlD
Maprotiline—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00138	0.00662	CbGeAlD
Maprotiline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00337	CcSEcCtD
Maprotiline—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00137	0.00659	CbGeAlD
Maprotiline—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00137	0.00657	CbGeAlD
Maprotiline—Rash—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00334	CcSEcCtD
Maprotiline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00334	CcSEcCtD
Maprotiline—Headache—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00332	CcSEcCtD
Maprotiline—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00136	0.0065	CbGeAlD
Maprotiline—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00131	0.00626	CbGeAlD
Maprotiline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00314	CcSEcCtD
Maprotiline—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00125	0.006	CbGeAlD
Maprotiline—CHRM3—nervous system—amyotrophic lateral sclerosis	0.00121	0.00581	CbGeAlD
Maprotiline—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.0012	0.00574	CbGeAlD
Maprotiline—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00117	0.0056	CbGeAlD
Maprotiline—HTR7—nervous system—amyotrophic lateral sclerosis	0.00116	0.00553	CbGeAlD
Maprotiline—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00115	0.00553	CbGeAlD
Maprotiline—CHRM2—brain—amyotrophic lateral sclerosis	0.00114	0.00546	CbGeAlD
Maprotiline—SLC6A3—brain—amyotrophic lateral sclerosis	0.00114	0.00544	CbGeAlD
Maprotiline—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00111	0.00533	CbGeAlD
Maprotiline—HTR2C—brain—amyotrophic lateral sclerosis	0.0011	0.00526	CbGeAlD
Maprotiline—DRD2—nervous system—amyotrophic lateral sclerosis	0.00109	0.00523	CbGeAlD
Maprotiline—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00109	0.00521	CbGeAlD
Maprotiline—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00504	CbGeAlD
Maprotiline—CHRM1—brain—amyotrophic lateral sclerosis	0.00104	0.00497	CbGeAlD
Maprotiline—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00103	0.00492	CbGeAlD
Maprotiline—ABCB1—embryo—amyotrophic lateral sclerosis	0.000983	0.00471	CbGeAlD
Maprotiline—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000959	0.00459	CbGeAlD
Maprotiline—CHRM3—brain—amyotrophic lateral sclerosis	0.000928	0.00444	CbGeAlD
Maprotiline—SLC6A2—brain—amyotrophic lateral sclerosis	0.000916	0.00439	CbGeAlD
Maprotiline—HTR7—brain—amyotrophic lateral sclerosis	0.000883	0.00423	CbGeAlD
Maprotiline—HRH1—nervous system—amyotrophic lateral sclerosis	0.000862	0.00413	CbGeAlD
Maprotiline—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000855	0.0041	CbGeAlD
Maprotiline—DRD2—brain—amyotrophic lateral sclerosis	0.000835	0.004	CbGeAlD
Maprotiline—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00083	0.00398	CbGeAlD
Maprotiline—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00072	0.00345	CbGeAlD
Maprotiline—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000693	0.00332	CbGeAlD
Maprotiline—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000678	0.00325	CbGeAlD
Maprotiline—HRH1—brain—amyotrophic lateral sclerosis	0.000659	0.00316	CbGeAlD
Maprotiline—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000656	0.00314	CbGeAlD
Maprotiline—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000632	0.00303	CbGeAlD
Maprotiline—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000628	0.00301	CbGeAlD
Maprotiline—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000617	0.00296	CbGeAlD
Maprotiline—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00056	0.00268	CbGeAlD
Maprotiline—HTR2A—brain—amyotrophic lateral sclerosis	0.000551	0.00264	CbGeAlD
Maprotiline—CYP2D6—brain—amyotrophic lateral sclerosis	0.000502	0.0024	CbGeAlD
Maprotiline—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000472	0.00226	CbGeAlD
Maprotiline—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000454	0.00218	CbGeAlD
Maprotiline—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000444	0.00213	CbGeAlD
Maprotiline—ABCB1—brain—amyotrophic lateral sclerosis	0.000361	0.00173	CbGeAlD
Maprotiline—CHRM4—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.67e-05	0.000961	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.65e-05	0.000954	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.64e-05	0.000946	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.64e-05	0.000944	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.63e-05	0.000943	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.63e-05	0.000943	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSR—amyotrophic lateral sclerosis	1.63e-05	0.000941	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.63e-05	0.000938	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.62e-05	0.000936	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.62e-05	0.000933	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.62e-05	0.000933	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.61e-05	0.000931	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.61e-05	0.000931	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.61e-05	0.00093	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.6e-05	0.000921	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.6e-05	0.000921	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.54e-05	0.00089	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.53e-05	0.000885	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.53e-05	0.000883	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.000879	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.51e-05	0.000874	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.49e-05	0.000862	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.49e-05	0.00086	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.49e-05	0.000858	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.48e-05	0.000855	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.48e-05	0.000855	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.48e-05	0.000854	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.48e-05	0.000853	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.47e-05	0.000851	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.46e-05	0.000844	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.44e-05	0.000828	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.42e-05	0.000822	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.4e-05	0.000809	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.4e-05	0.000807	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.39e-05	0.000805	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.39e-05	0.000804	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.39e-05	0.000804	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.39e-05	0.000802	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.39e-05	0.000802	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.38e-05	0.000794	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.36e-05	0.000782	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.35e-05	0.000779	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CHAT—amyotrophic lateral sclerosis	1.34e-05	0.000773	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.33e-05	0.00077	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.33e-05	0.000767	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.33e-05	0.000765	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.32e-05	0.000762	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.32e-05	0.00076	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.32e-05	0.000759	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.31e-05	0.000755	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.31e-05	0.000754	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.3e-05	0.000753	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.3e-05	0.000752	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.3e-05	0.000751	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.3e-05	0.000749	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.29e-05	0.000742	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.28e-05	0.000741	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.28e-05	0.000738	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.28e-05	0.000736	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.27e-05	0.000734	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.26e-05	0.000729	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.23e-05	0.00071	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.21e-05	0.0007	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.18e-05	0.000682	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.18e-05	0.000682	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.18e-05	0.00068	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.17e-05	0.000678	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.16e-05	0.00067	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.15e-05	0.000663	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.15e-05	0.000662	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.14e-05	0.000661	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.14e-05	0.000659	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.14e-05	0.000658	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.14e-05	0.000656	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.14e-05	0.000656	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.13e-05	0.000654	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.13e-05	0.000652	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.13e-05	0.00065	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.12e-05	0.000648	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.12e-05	0.000647	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.12e-05	0.000647	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.12e-05	0.000646	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.11e-05	0.00064	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.1e-05	0.000633	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000628	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.08e-05	0.000625	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.07e-05	0.00062	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.06e-05	0.000611	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.06e-05	0.00061	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.03e-05	0.000597	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.03e-05	0.000593	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.02e-05	0.00059	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1e-05	0.000578	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.79e-06	0.000565	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	9.75e-06	0.000563	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.61e-06	0.000555	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.6e-06	0.000554	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.44e-06	0.000545	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.42e-06	0.000544	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.39e-06	0.000542	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.36e-06	0.00054	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.34e-06	0.000539	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.27e-06	0.000535	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.27e-06	0.000535	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.19e-06	0.00053	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.17e-06	0.000529	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.14e-06	0.000528	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.11e-06	0.000526	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.02e-06	0.000521	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.95e-06	0.000517	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.94e-06	0.000516	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.75e-06	0.000505	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.71e-06	0.000503	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.5e-06	0.00049	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.48e-06	0.000489	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.38e-06	0.000484	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.38e-06	0.000484	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.34e-06	0.000482	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.33e-06	0.000481	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.3e-06	0.000479	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.27e-06	0.000478	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	8.26e-06	0.000477	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.23e-06	0.000475	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.19e-06	0.000473	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.01e-06	0.000462	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.98e-06	0.000461	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.89e-06	0.000455	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.88e-06	0.000455	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.76e-06	0.000448	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.74e-06	0.000447	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.72e-06	0.000445	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.7e-06	0.000444	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.69e-06	0.000444	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.62e-06	0.00044	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.57e-06	0.000437	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.52e-06	0.000434	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.4e-06	0.000427	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.28e-06	0.00042	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.27e-06	0.00042	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.26e-06	0.000419	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.24e-06	0.000418	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.22e-06	0.000416	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.2e-06	0.000415	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.17e-06	0.000414	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.15e-06	0.000412	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.04e-06	0.000407	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.96e-06	0.000402	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.93e-06	0.0004	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.92e-06	0.000399	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.89e-06	0.000398	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.87e-06	0.000397	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.83e-06	0.000394	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.81e-06	0.000393	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.78e-06	0.000391	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.77e-06	0.000391	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.61e-06	0.000382	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.48e-06	0.000374	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.42e-06	0.000371	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.19e-06	0.000357	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.03e-06	0.000348	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.93e-06	0.000342	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.92e-06	0.000342	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.92e-06	0.000342	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.9e-06	0.000341	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.88e-06	0.000339	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.82e-06	0.000336	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.68e-06	0.000328	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.67e-06	0.000327	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.59e-06	0.000323	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.58e-06	0.000322	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.57e-06	0.000321	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.55e-06	0.00032	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.53e-06	0.000319	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.48e-06	0.000316	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	5.44e-06	0.000314	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.36e-06	0.000309	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.28e-06	0.000305	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.01e-06	0.000289	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.93e-06	0.000285	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.92e-06	0.000284	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.9e-06	0.000283	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.89e-06	0.000282	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.84e-06	0.000279	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.66e-06	0.000269	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.59e-06	0.000265	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.58e-06	0.000264	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.57e-06	0.000264	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.56e-06	0.000263	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.56e-06	0.000263	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.55e-06	0.000263	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.51e-06	0.00026	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.37e-06	0.000252	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.31e-06	0.000249	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.31e-06	0.000249	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.3e-06	0.000248	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.24e-06	0.000245	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.2e-06	0.000242	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.12e-06	0.000238	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.07e-06	0.000235	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.95e-06	0.000228	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.9e-06	0.000225	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.87e-06	0.000223	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.85e-06	0.000222	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.79e-06	0.000219	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.78e-06	0.000218	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.77e-06	0.000218	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.76e-06	0.000217	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.73e-06	0.000215	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.72e-06	0.000215	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.65e-06	0.000211	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.65e-06	0.00021	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.5e-06	0.000202	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.45e-06	0.000199	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.36e-06	0.000194	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.35e-06	0.000193	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.25e-06	0.000188	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.18e-06	0.000183	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.97e-06	0.000171	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.92e-06	0.000169	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.92e-06	0.000168	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.91e-06	0.000168	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.9e-06	0.000168	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.89e-06	0.000167	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.87e-06	0.000165	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.85e-06	0.000165	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.8e-06	0.000162	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.76e-06	0.000159	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.76e-06	0.000159	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.76e-06	0.000159	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.75e-06	0.000159	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.74e-06	0.000158	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.73e-06	0.000158	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.71e-06	0.000156	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.64e-06	0.000153	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.52e-06	0.000145	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.48e-06	0.000143	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.47e-06	0.000143	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.46e-06	0.000142	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.46e-06	0.000142	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.43e-06	0.00014	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.37e-06	0.000137	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.23e-06	0.000129	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.16e-06	0.000124	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.9e-06	0.00011	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.89e-06	0.000109	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.87e-06	0.000108	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.87e-06	0.000108	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.86e-06	0.000107	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.86e-06	0.000107	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.84e-06	0.000106	CbGpPWpGaD
